{"organizations": [], "uuid": "e49fe956917dd1fbf25c63b227b24f88f48ab33e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/07/16/idUSASM000B1A20150716", "country": "US", "title": "BRIEF-Bionor Pharma agrees with Celgene on continued supply of romidepsin", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "BRIEF-Bionor Pharma agrees with Celgene on continued supply of romidepsin | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-07-16T09:41:00.000+03:00", "replies_count": 0, "uuid": "e49fe956917dd1fbf25c63b227b24f88f48ab33e"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/07/16/idUSASM000B1A20150716", "ord_in_thread": 0, "title": "BRIEF-Bionor Pharma agrees with Celgene on continued supply of romidepsin", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "July 16 Bionor Pharma ASA :\n* Enters into romidepsin supply agreement enabling advancement of its HIV therapeutic vaccine with Vacc-4x into full scale clinical Phase II\n* Says has signed an agreement with Celgene Corporation securing a continued supply of romidepsin (Istodax) Source text for Eikon:\nFurther company coverage: (Gdynia Newsroom)", "external_links": [], "published": "2015-07-16T09:41:00.000+03:00", "crawled": "2015-07-16T08:52:58.000+03:00", "highlightTitle": ""}